Class information for:
Level 1: ARGININE DEIMINASE//ARGININE DEPRIVATION//ADI PEG20

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
22802 312 35.7 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1850 5585 ARGINASE//ORNITHINE TRANSCARBAMYLASE DEFICIENCY//SLC25A13

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ARGININE DEIMINASE Author keyword 52 58% 20% 61
2 ARGININE DEPRIVATION Author keyword 21 85% 4% 11
3 ADI PEG20 Author keyword 8 75% 2% 6
4 ARGININOSUCCINATE SYNTHETASE Author keyword 8 25% 9% 27
5 ARGININOSUCCINATE SYNTHETASE ASS Author keyword 4 75% 1% 3
6 AZURIN Author keyword 3 12% 8% 26
7 H8 EPITOPE Author keyword 3 100% 1% 3
8 PHOENIX PHARMACOL INC Address 3 100% 1% 3
9 RECOMBINANT ARGININE DEIMINASE Author keyword 3 100% 1% 3
10 RECOMBINANT HUMAN ARGINASE Author keyword 3 100% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ARGININE DEIMINASE 52 58% 20% 61 Search ARGININE+DEIMINASE Search ARGININE+DEIMINASE
2 ARGININE DEPRIVATION 21 85% 4% 11 Search ARGININE+DEPRIVATION Search ARGININE+DEPRIVATION
3 ADI PEG20 8 75% 2% 6 Search ADI+PEG20 Search ADI+PEG20
4 ARGININOSUCCINATE SYNTHETASE 8 25% 9% 27 Search ARGININOSUCCINATE+SYNTHETASE Search ARGININOSUCCINATE+SYNTHETASE
5 ARGININOSUCCINATE SYNTHETASE ASS 4 75% 1% 3 Search ARGININOSUCCINATE+SYNTHETASE+ASS Search ARGININOSUCCINATE+SYNTHETASE+ASS
6 AZURIN 3 12% 8% 26 Search AZURIN Search AZURIN
7 H8 EPITOPE 3 100% 1% 3 Search H8+EPITOPE Search H8+EPITOPE
8 RECOMBINANT ARGININE DEIMINASE 3 100% 1% 3 Search RECOMBINANT+ARGININE+DEIMINASE Search RECOMBINANT+ARGININE+DEIMINASE
9 RECOMBINANT HUMAN ARGINASE 3 100% 1% 3 Search RECOMBINANT+HUMAN+ARGINASE Search RECOMBINANT+HUMAN+ARGINASE
10 ABPP PROBE 2 67% 1% 2 Search ABPP+PROBE Search ABPP+PROBE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MYCOPLASMA ARGININI 112 97% 10% 32
2 DEIMINASE TREATMENT 45 94% 5% 16
3 ARGININOSUCCINATE SYNTHETASE EXPRESSION 27 92% 4% 11
4 REDOX PROTEIN AZURIN 21 85% 4% 11
5 ARGININE DEIMINASE TREATMENT 11 57% 4% 13
6 ARGININOSUCCINATE SYNTHETASE 10 19% 16% 49
7 BACTERIAL CUPREDOXIN AZURIN 10 73% 3% 8
8 ADI PEG 20 8 75% 2% 6
9 RECOMBINANT HUMAN ARGINASE 8 75% 2% 6
10 CUPREDOXIN AZURIN 8 100% 2% 5

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Arginine deprivation in cancer therapy 2015 2 20 90%
Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges 2013 20 91 58%
Arginine deprivation as a targeted therapy for cancer 2008 65 63 52%
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer 2010 64 75 28%
Arginine deiminase, a potential anti-tumor drug 2008 30 45 58%
Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma 2010 30 52 40%
Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents 2012 1 1 100%
The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials 2014 3 72 33%
Arginine deprivation and metabolomics: Important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells 2005 36 18 56%
Targeting arginine metabolism pathway to treat arginine-dependent cancers 2015 0 69 81%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PHOENIX PHARMACOL INC 3 100% 1.0% 3
2 LO KA CHUNG NAT ANTICANC DRUG DEV 1 31% 1.3% 4
3 SYLVERSTER COMPREHENS CANC 1 100% 0.6% 2
4 BIOPHYS NANOSCI 1 14% 2.9% 9
5 BK21 PROGRAM MED SCI 1 23% 1.0% 3
6 BARTS CANC CANC UK EXCELLENCE 1 50% 0.3% 1
7 CANC STUDIES RAYNE 1 50% 0.3% 1
8 EDUC TECHNOL SIMULAT TRAINING 1 50% 0.3% 1
9 MED 111GI 1 50% 0.3% 1
10 PUSAN UNIV HOSPMED 1 50% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000150593 ARGINASE//NOR NOHA//ARGINASE II
2 0.0000122405 METHIONINE DEPENDENCE//METHIONINASE//L METHIONINE GAMMA LYASE
3 0.0000099063 ARGININE REPRESSOR//ARGININE REPRESSOR PROTEIN//ARGR
4 0.0000080506 CITRULLINE//HUBEI ANIM NUTR FEED SCI//HUNAN ENGN ANIM POULTRY SCI
5 0.0000078171 SUTHERLANDIA FRUTESCENS//L CANAVANINE//BIOCHEM ECOL
6 0.0000072048 LAPTM4B//LAPTM4B 35//LYSOSOMAL PROTEIN TRANSMEMBRANE 4 BETA
7 0.0000065864 BACTOFECTION//BACTERIAL THERAPY//SALMONELLA TYPHIMURIUM A1 R
8 0.0000063374 CITRULLINATION//PEPTIDYLARGININE DEIMINASE//ANTIPERINUCLEAR FACTOR
9 0.0000055826 RESEARCH FRONTIERS//19TH CENTURY PHYSIOLOGY//CELL PATHOL UNIT
10 0.0000053700 L ASPARAGINASE//ASPARAGINASE//ERWINIA ASPARAGINASE